All In Biotech

Drug Trial Radar · NCT00785629

A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD

A Double Blind Randomized Placebo Controlled Trial of Maintenance of Normal Serum Phosphorus in Chronic Kidney Disease (CKD)

Last checked: Nov 20, 2026Latest source record: Oct 30, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 148 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

148

Actual

Start

Feb 2009

Primary completion

Jul 2011

Study completion Jul 2011

Sponsor

Lead sponsor
Denver Nephrologists, P.C.Academic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Shire; Fresenius Medical Care North America; Genzyme, a Sanofi Company; Novartis Pharmaceuticals; DaVita, Inc.
First posted
Nov 5, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.

Conditions

  • Chronic Kidney Disease

Interventions

  • Calcium acetateDrug

  • Lanthanum CarbonateDrug

  • Sevelamer CarbonateDrug

  • PlaceboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Serum PhosphorusTime frame: months 3-9

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Denver Nephrologists, PC

    Denver, Colorado

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.